A significant proportion of patients with cancer who recover from COVID-19 may experience COVID-19 sequelae in the early post-infection phase, which negatively affect the continuity of care and oncological outcome. The long-term prevalence and clinical impact of post-COVID-19 syndrome in patients with cancer are largely unknown.
